BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 38672489)

  • 21.
    Yadati T; Houben T; Bitorina A; Shiri-Sverdlov R
    Cells; 2020 Jul; 9(7):. PubMed ID: 32668602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes.
    Blondy S; David V; Verdier M; Mathonnet M; Perraud A; Christou N
    Cancer Sci; 2020 Sep; 111(9):3142-3154. PubMed ID: 32536012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy triggers CTSD (cathepsin D) maturation and localization inside cells to promote apoptosis.
    Di YQ; Han XL; Kang XL; Wang D; Chen CH; Wang JX; Zhao XF
    Autophagy; 2021 May; 17(5):1170-1192. PubMed ID: 32324083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of cathepsin D is required for L1-mediated colon cancer progression.
    Basu S; Cheriyamundath S; Gavert N; Brabletz T; Haase G; Ben-Ze'ev A
    Oncotarget; 2019 Aug; 10(50):5217-5228. PubMed ID: 31497251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications.
    Ferro S; Azevedo-Silva J; Casal M; Côrte-Real M; Baltazar F; Preto A
    Oncotarget; 2016 Oct; 7(43):70639-70653. PubMed ID: 28874966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yeast as a tool to explore cathepsin D function.
    Pereira H; Oliveira CS; Castro L; Preto A; Chaves SR; Côrte-Real M
    Microb Cell; 2015 Jul; 2(7):225-234. PubMed ID: 28357298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria and Cancer.
    Vyas S; Zaganjor E; Haigis MC
    Cell; 2016 Jul; 166(3):555-566. PubMed ID: 27471965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.
    Palma S; Zwenger AO; Croce MV; Abba MC; Lacunza E
    Clin Colorectal Cancer; 2016 Jun; 15(2):104-15. PubMed ID: 26777471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging metabolic heterogeneity in cancer.
    Sengupta D; Pratx G
    Mol Cancer; 2016 Jan; 15():4. PubMed ID: 26739333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of somatic mutations on patterns of metastasis in colorectal cancer.
    Lipsyc M; Yaeger R
    J Gastrointest Oncol; 2015 Dec; 6(6):645-9. PubMed ID: 26697197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
    Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
    Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
    Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
    Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria.
    Oliveira CS; Pereira H; Alves S; Castro L; Baltazar F; Chaves SR; Preto A; Côrte-Real M
    Cell Death Dis; 2015 Jun; 6(6):e1788. PubMed ID: 26086961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is reliance on mitochondrial respiration a "chink in the armor" of therapy-resistant cancer?
    Wolf DA
    Cancer Cell; 2014 Dec; 26(6):788-795. PubMed ID: 25490445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: emerging new roles in mitochondrial pathophysiology.
    Antoniel M; Giorgio V; Fogolari F; Glick GD; Bernardi P; Lippe G
    Int J Mol Sci; 2014 Apr; 15(5):7513-36. PubMed ID: 24786291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67.
    Shin IY; Sung NY; Lee YS; Kwon TS; Si Y; Lee YS; Oh ST; Lee IK
    Gut Liver; 2014 Jan; 8(1):13-23. PubMed ID: 24516696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cellular metabolism to improve cancer therapeutics.
    Zhao Y; Butler EB; Tan M
    Cell Death Dis; 2013 Mar; 4(3):e532. PubMed ID: 23470539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release.
    Marques C; Oliveira CS; Alves S; Chaves SR; Coutinho OP; Côrte-Real M; Preto A
    Cell Death Dis; 2013 Feb; 4(2):e507. PubMed ID: 23429293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.